Literature DB >> 10762298

Haemolytic uraemic syndrome: prognostic factors.

D A Green1, W G Murphy, W S Uttley.   

Abstract

Haemolytic uraemic syndrome (HUS) associated with Escherichia coli O157:H7 is the commonest cause of acute renal failure (ARF) in childhood. Production of verotoxin by the organism is pivotal in the pathogenesis of the disease. Verotoxin binds to a receptor on blood and endothelial cells, expressed as the P1 blood group antigen on red blood cells. A protective effect of the P1 phenotype has been proposed in this disease. This study investigates prognostic factors and the relationship between outcome and P1 phenotype in 27 cases of diarrhoea-associated HUS. A poor outcome as defined by the presence of chronic renal failure (CRF), hypertension or proteinuria on 6 month follow-up was associated with the age of the patient at presentation and with the following clinical markers: maximum WBC and duration of raised WBC, duration of anuria and duration of need for dialysis. None of these outcome measures or prognostic factors, and no extra-renal manifestations of the disease were associated with P1 phenotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762298     DOI: 10.1046/j.1365-2257.2000.00272.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  6 in total

1.  Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.

Authors:  Craig S Wong; Jody C Mooney; John R Brandt; Amy O Staples; Srdjan Jelacic; Daniel R Boster; Sandra L Watkins; Phillip I Tarr
Journal:  Clin Infect Dis       Date:  2012-03-19       Impact factor: 9.079

2.  In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology.

Authors:  Michelle Tsai; Ashley Kita; Joseph Leach; Ross Rounsevell; James N Huang; Joel Moake; Russell E Ware; Daniel A Fletcher; Wilbur A Lam
Journal:  J Clin Invest       Date:  2011-12-12       Impact factor: 14.808

3.  Endothelialized microfluidics for studying microvascular interactions in hematologic diseases.

Authors:  David R Myers; Yumiko Sakurai; Reginald Tran; Byungwook Ahn; Elaissa Trybus Hardy; Robert Mannino; Ashley Kita; Michelle Tsai; Wilbur A Lam
Journal:  J Vis Exp       Date:  2012-06-22       Impact factor: 1.355

Review 4.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  Trochanteric area pain, the result of a quartet of bursal inflammation.

Authors:  Bruce Rothschild
Journal:  World J Orthop       Date:  2013-07-18

6.  Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children.

Authors:  Lars Krogvold; Thore Henrichsen; Anna Bjerre; Damien Brackman; Henrik Dollner; Helga Gudmundsdottir; Gaute Syversen; Pål Aksel Næss; Hans Jacob Bangstad
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-07-28       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.